科塔克替代投资公司投资1445亿卢比收购Viatris API业务给Matrix制药。

Kotak Alt invests Rs 1,445 cr to acquire Viatris API biz for Matrix Pharma

作者： Anjali Singh

Kotak Alternative Asset Managers: This acquisition will make Matrix the second-largest Indian active pharmaceutical ingredients (API) player with global leadership in antiretroviral (ARV) APIs

科塔克替代资产管理公司：此次收购将使Matrix成为印度第二大活性药物成分（API）制造商，并在抗逆转录病毒（ARV）API领域拥有全球领先地位。

This acquisition will make Matrix the second-largest Indian active pharmaceutical ingredients (API) player with global leadership in antiretroviral (ARV) APIs
Photo: Bloomberg
Anjali SinghMumbai
K… [+1849 chars]

此次收购将使Matrix成为印度第二大活性药物成分（API）企业，并在抗逆转录病毒（ARV）API领域拥有全球领导地位
照片：彭博社
安贾丽·辛格孟买
K… [+1849个字符]

原文链接：Business Standard